Search research articles
Contact Us
Filters
Showing results (31-40 of 131) with videos related to
Page
of 14
Sort By:
The British Journal of Radiology
|
July 8, 2021
Radiomics in cervical and endometrial cancer
Lucia Manganaro, Gabriele Maria Nicolino, Miriam Dolciami, et al.
European Journal of Haematology
|
October 18, 2006
Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab
Elisa Gallerani, Erika Lerch, Elena Romagnani, et al.
Hematological Oncology
|
November 8, 2023
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?
Carmen de Ramon Ortiz, Sisi Wang, Anastasios Stathis, et al.
Tumori
|
October 3, 2017
Uncommon somatic mutations in metastatic NUT midline carcinoma
Stefano Cavalieri, Anastasios Stathis, Alessandra Fabbri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 14, 2017
Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma
Karin Ribi, Stéphanie Rondeau, Felicitas Hitz, et al.
British Journal of Haematology
|
April 4, 2018
Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma
Filippo Spriano, Elaine Y Chung, Nicolo' Panini, et al.
Investigational New Drugs
|
August 28, 2021
A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
Yannis Metaxas, Carmen Kahatt, Vicente Alfaro, et al.
Investigational New Drugs
|
February 18, 2018
Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study
Anastasios Stathis, Ian W Flinn, Sumit Madan, et al.
European Journal of Clinical Investigation
|
December 24, 2018
Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis
Ricardo Pereira Mestre, Giorgio Treglia, Matteo Ferrari, et al.
Bone Reports
|
August 14, 2024
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study
Michael Mark, Alfonso Rojas Mora, Thomas Winder, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 131) with videos related to
Sort By:
Page
of 14
The British Journal of Radiology
|
July 8, 2021
Radiomics in cervical and endometrial cancer
Lucia Manganaro, Gabriele Maria Nicolino, Miriam Dolciami, et al.
European Journal of Haematology
|
October 18, 2006
Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab
Elisa Gallerani, Erika Lerch, Elena Romagnani, et al.
Hematological Oncology
|
November 8, 2023
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?
Carmen de Ramon Ortiz, Sisi Wang, Anastasios Stathis, et al.
Tumori
|
October 3, 2017
Uncommon somatic mutations in metastatic NUT midline carcinoma
Stefano Cavalieri, Anastasios Stathis, Alessandra Fabbri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 14, 2017
Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma
Karin Ribi, Stéphanie Rondeau, Felicitas Hitz, et al.
British Journal of Haematology
|
April 4, 2018
Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma
Filippo Spriano, Elaine Y Chung, Nicolo' Panini, et al.
Investigational New Drugs
|
August 28, 2021
A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
Yannis Metaxas, Carmen Kahatt, Vicente Alfaro, et al.
Investigational New Drugs
|
February 18, 2018
Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study
Anastasios Stathis, Ian W Flinn, Sumit Madan, et al.
European Journal of Clinical Investigation
|
December 24, 2018
Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis
Ricardo Pereira Mestre, Giorgio Treglia, Matteo Ferrari, et al.
Bone Reports
|
August 14, 2024
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study
Michael Mark, Alfonso Rojas Mora, Thomas Winder, et al.
Page
of 14